alexa Community drug expenditure and recent cost containment measures.
Pharmaceutical Sciences

Pharmaceutical Sciences

Pharmacoeconomics: Open Access

Author(s): Walshe V, Kenneally M

Abstract Share this page

Abstract The annual cost of medicines under the community drugs schemes increased from Euro 564 m in 2000 to Euro 1,961 m in 2009 before falling an estimated 8\% by 2011. Escalating public health costs, fiscal stress and the unsustainability of the previous growth in expenditure has led to the increased use of pharmaceutical cost containment measures in Ireland. Collectively, these measures are estimated to have reduced public expenditure on community drugs by Euro 380 m in 2011 and involve addressing; (1) the ex-factory price of drugs including price cuts of up to 40\% on off-patent and generic drugs leading to an estimated Euro 200 m saving (53\%); (2) pharmacy dispensing fees and mark-ups via a new dispensing fee structure and reducing both retail and wholesale mark-ups with a Euro 100 m saving (26\%); and (3) scheme coverage and patient co-payments including restricting scheme coverage for persons over 70 years and increasing the level of co-payments with savings of Euro 80 m (21\%).
This article was published in Ir Med J and referenced in Pharmacoeconomics: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • Clinical Trials
    September 11-13, 2017 San Antonio, Texas, USA

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version